Structural insights into the agonists binding and receptor selectivity of human histamine H
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
20 10 2023
20 10 2023
Historique:
received:
07
08
2022
accepted:
04
10
2023
medline:
1
11
2023
pubmed:
21
10
2023
entrez:
20
10
2023
Statut:
epublish
Résumé
Histamine is a biogenic amine that participates in allergic and inflammatory processes by stimulating histamine receptors. The histamine H
Identifiants
pubmed: 37863901
doi: 10.1038/s41467-023-42260-z
pii: 10.1038/s41467-023-42260-z
pmc: PMC10589313
doi:
Substances chimiques
Histamine
820484N8I3
Receptors, Histamine H4
0
Receptors, G-Protein-Coupled
0
Receptors, Histamine
0
Histamine Agonists
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6538Informations de copyright
© 2023. Springer Nature Limited.
Références
Panula, P. et al. International union of basic and clinical pharmacology. XCVIII. histamine receptors. Pharmacol. Rev. 67, 601–655 (2015).
pubmed: 26084539
pmcid: 4485016
Ash, A. S. F. & Schild, H. O. Receptors mediating some actions of histamine. Br. J. Pharmacol. Chemother. 27, 427–439 (1966).
pubmed: 4381779
pmcid: 1510832
Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R. & Parsons, E. M. Definition and antagonism of histamine H2-Receptors. Nature 236, 385–390 (1972).
pubmed: 4401751
Thurmond, R. L. The histamine H4 receptor: From orphan to the clinic. Front. Pharmacol. 6, 1–11 (2015).
Arrang, J. M., Garbarg, M. & Schwartz, J. C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302, 832–837 (1983).
pubmed: 6188956
Lovenberg, T. W. et al. Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol. 55, 1101–1107 (1999).
pubmed: 10347254
Schwartz, J. C. The histamine H3 receptor: From discovery to clinical trials with pitolisant. Br. J. Pharmacol. 163, 713–721 (2011).
pubmed: 21615387
pmcid: 3111674
Oda, T., Morikawa, N., Saito, Y., Masuho, Y. & Matsumoto, S. I. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. 275, 36781–36786 (2000).
pubmed: 10973974
Nakamura, T., Itadani, H., Hidaka, Y., Ohta, M. & Tanaka, K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem. Biophys. Res. Commun. 279, 615–620 (2000).
pubmed: 11118334
Liu, C. et al. Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol. Pharmacol. 59, 420–426 (2001).
pubmed: 11179434
Morse, K. L. et al. Cloning and characterization of a novel human histamine receptor. J. Pharmacol. Exp. Ther. 296, 1058–1066 (2001).
pubmed: 11181941
Nguyen, T. et al. Discovery of a novel member of the histamine receptor family. Mol. Pharmacol. 59, 427–433 (2001).
pubmed: 11179435
Gutzmer, R. Pathogenetic and therapeutic implications of the histamine H4 receptor in inflammatory skin diseases and pruritus. Front. Biosci. S3, 985 (2011).
Cramp, S. et al. Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists. Bioorganic Med. Chem. Lett. 20, 2516–2519 (2010).
Marson, C. M. Targeting the histamine H4 receptor. Chem. Rev. 111, 7121–7156 (2011).
pubmed: 21842846
Zampeli, E. & Tiligada, E. The role of histamine H 4 receptor in immune and inflammatory disorders. British J. Pharmacol. 157, 24–33 (2009).
Sadek, B. & Stark, H. Cherry-picked ligands at histamine receptor subtypes. Neuropharmacology 106, 56–73 (2016).
pubmed: 26581501
Corrêa, M. F. & Fernandes, J. P. D. S. Histamine H4 receptor ligands: Future applications and state of art. Chem. Biol. Drug Des. 85, 461–480 (2015).
pubmed: 25228262
Shimamura, T. et al. Structure of the human histamine H 1 receptor complex with doxepin. Nature 475, 65–72 (2011).
pubmed: 21697825
pmcid: 3131495
Xia, R. et al. Cryo-EM structure of the human histamine H1 receptor/Gq complex. Nat. Commun. 12, 1–9 (2021).
Inoue, A. et al. Illuminating G-protein-coupling selectivity of GPCRs. Cell 177, 1933–1947.e25 (2019).
pubmed: 31160049
pmcid: 6773469
Rasmussen, S. G. F. et al. Crystal structure of the β2 adrenergic receptor–Gs protein complex. Nat. 2011 4777366 477, 549–555 (2011).
Maeda, S. et al. Development of an antibody fragment that stabilizes GPCR/G-protein complexes. Nat. Commun. 9, (2018).
Inoue, A. et al. TGFα shedding assay: An accurate and versatile method for detecting GPCR activation. Nat. Methods 9, 1021–1029 (2012).
pubmed: 22983457
Michino, M. et al. What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands? Pharmacol. Rev. 67, 198–213 (2015).
pubmed: 25527701
pmcid: 4279073
Zhuang, Y. et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Cell 184, 931–942.e18 (2021).
pubmed: 33571431
pmcid: 8215686
Im, D. et al. Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone. Nat. Commun. 11, 1–11 (2020).
Kooistra, A. J., Kuhne, S., De Esch, I. J. P., Leurs, R. & De Graaf, C. A structural chemogenomics analysis of aminergic GPCRs: Lessons for histamine receptor ligand design. Br. J. Pharmacol. 170, 101–126 (2013).
pubmed: 23713847
pmcid: 3764853
Jongejan, A. et al. Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations. J. Chem. Inf. Model. 48, 1455–1463 (2008).
pubmed: 18553960
Shin, N. et al. Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor. Mol. Pharmacol. 62, 38–47 (2002).
pubmed: 12065753
Lim, H. D. et al. Molecular determinants of ligand binding to H4R species variants. Mol. Pharmacol. 77, 734–743 (2010).
pubmed: 20103609
van der Goot, H., Schepers, M., Sterk, G. & Timmerman, H. Isothiourea analogues of histamine as potent agonists or antagonists of the histamine H3-receptor. Eur. J. Med. Chem. 27, 511–517 (1992).
Garbarg, M. et al. S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.J. Pharmacol. Exp. Ther. 263, 304–310 (1992).
pubmed: 1383495
Mehta, P. et al. Enigmatic histamine receptor h4 for potential treatment of multiple inflammatory, autoimmune, and related diseases. Life 10, (2020).
Feng, Z., Hou, T. & Li, Y. Docking and MD study of histamine H4R based on the crystal structure of H1R. J. Mol. Graph. Model. 39, 1–12 (2013).
pubmed: 23220277
Schultes, S. et al. Mapping histamine H4 receptor-ligand binding modes. Medchemcomm 4, 193–204 (2013).
Katritch, V., Cherezov, V. & Stevens, R. C. Structure-function of the G protein-coupled receptor superfamily. Annu. Rev. Pharmacol. Toxicol. 53, 531–556 (2013).
pubmed: 23140243
Filipek, S. Molecular switches in GPCRs. Curr. Opin. Struct. Biol. 55, 114–120 (2019).
pubmed: 31082695
Robertson, M. J. et al. Structure determination of inactive-state GPCRs with a universal nanobody. Nat. Struct. Mol. Biol. 29, 1188–1195 (2022).
pubmed: 36396979
Peng, X. et al. Structural basis for recognition of antihistamine drug by human histamine receptor. Nat. Commun. 13, (2022).
Jablonowski, J. A. et al. The first potent and selective non-imidazole human histamine H4 receptor antagonists. J. Med. Chem. 46, 3957–3960 (2003).
pubmed: 12954048
Rosethorne, E. M. & Charlton, S. J. Agonist-biased signalling at the histamine H4 receptor: JNJ7777120 recruits beta-arrestin without activating G proteins. Mol. Pharmacol. 79, 749–757 (2010).
pubmed: 21134907
Nijmeijer, S. et al. Detailed analysis of biased histamine H4 receptor signalling by JNJ 7777120 analogues. Br. J. Pharmacol. 170, 78–88 (2013).
pubmed: 23351115
pmcid: 3764851
Thurmond, R. L. et al. Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979. J. Pharmacol. Exp. Ther. 349, 176–184 (2014).
pubmed: 24549371
Murata, Y. et al. Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis. J. Dermatol. 42, 129–139 (2015).
pubmed: 25491792
Wifling, D. et al. Molecular determinants for the high constitutive activity of the human histamine H4 receptor: Functional studies on orthologues and mutants. Br. J. Pharmacol. 172, 785–798 (2015).
pubmed: 24903527
Chun, E. et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 20, 967–976 (2012).
pubmed: 22681902
pmcid: 3375611
Nehmea, R. et al. Mini-G proteins: Novel tools for studying GPCRs in their active conformation. PLoS One 12, 1–26 (2017).
Carpenter, B., Nehmé, R., Warne, T., Leslie, A. G. W. & Tate, C. G. Structure of the adenosine A2A receptor bound to an engineered G protein. Nature 536, 104–107 (2016).
pubmed: 27462812
pmcid: 4979997
Liang, Y. L. et al. Dominant negative g proteins enhance formation and purification of agonist-gpcr-g protein complexes for structure determination. ACS Pharmacol. Transl. Sci. 1, 12–20 (2018).
pubmed: 32219201
pmcid: 7089020
Kim, K. et al. Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor. Cell 182, 1574–1588.e19 (2020).
pubmed: 32946782
pmcid: 7593816
Maeda, S., Qu, Q., Robertson, M. J., Skiniotis, G. & Kobilka, B. K. Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes. Science (80-.). 364, 552–557 (2019).
Wang, Y. et al. Molecular recognition of an acyl-peptide hormone and activation of ghrelin receptor. Nat. Commun. 12, 5064 (2021).
pubmed: 34417468
pmcid: 8379176
Duan, J. et al. Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy. Nat. Commun. 11, 1–10 (2020).
pubmed: 31911652
pmcid: 6946686
Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005).
pubmed: 16182563
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. CryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
pubmed: 28165473
Bepler, T., Kelley, K., Noble, A. J. & Berger, B. Topaz-Denoise: general deep denoising models for cryoEM and cryoET. Nat. Commun. 11, 1–12 (2020).
Wagner, T. et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. 2, 1–13 (2019).
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
pubmed: 33257830
Terwilliger, T. C., Sobolev, O. V., Afonine, P. V. & Adams, P. D. Automated map sharpening by maximization of detail and connectivity. Acta Crystallogr. Sect. D Struct. Biol. 74, 545–559 (2018).
Adams, P. D. et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 213–221 (2010).
Yamashita, K., Palmer, C. M., Burnley, T. & Murshudov, G. N. Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr. Sect. D Struct. Biol. 77, 1282–1291 (2021).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 486–501 (2010).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. D Struct. Biol. 74, 531–544 (2018).
Goddard, T. D. et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
pubmed: 28710774
Friesner, R. A. et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J. Med. Chem. 47, 1739–1749 (2004).
pubmed: 15027865